Evidence map›Paper›PMID 38005995›Full record

ArticleVaccines2023

Vaccination with an HIV T-Cell Immunogen (HTI) Using DNA Primes Followed by a ChAdOx1-MVA Boost Is Immunogenic in Gut Microbiota-Depleted Mice despite Low IL-22 Serum Levels.

Aleix Elizalde-Torrent, Alessandra Borgognone, Maria Casadellà, Luis Romero-Martin, Tuixent Escribà, Mariona Parera, Yaiza Rosales-Salgado, Jorge Díaz-Pedroza, Francesc Català-Moll, Marc Noguera-Julian and 3 more

Open access · goldAbstract read
In one paragraph

Article in Vaccines, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 2 countries.

Aleix Elizalde-TorrentIrsicaixa-AIDS Research Institute, 08916 Barcelona, Spain.ORCID 0000-0001-7405-777X
Alessandra BorgognoneIrsicaixa-AIDS Research Institute, 08916 Barcelona, Spain.
Maria CasadellàIrsicaixa-AIDS Research Institute, 08916 Barcelona, Spain.ORCID 0000-0002-4115-2305
Luis Romero-MartinIrsicaixa-AIDS Research Institute, 08916 Barcelona, Spain.ORCID 0000-0003-1509-4882
Tuixent EscribàIrsicaixa-AIDS Research Institute, 08916 Barcelona, Spain.
Mariona PareraIrsicaixa-AIDS Research Institute, 08916 Barcelona, Spain.
Yaiza Rosales-SalgadoFundació Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol (IGTP), 08916 Badalona, Spain.
Jorge Díaz-PedrozaFundació Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol (IGTP), 08916 Badalona, Spain.
Francesc Català-MollIrsicaixa-AIDS Research Institute, 08916 Barcelona, Spain.
Marc Noguera-JulianIrsicaixa-AIDS Research Institute, 08916 Barcelona, Spain.ORCID 0000-0002-6194-1395
Christian BranderIrsicaixa-AIDS Research Institute, 08916 Barcelona, Spain.
Roger ParedesIrsicaixa-AIDS Research Institute, 08916 Barcelona, Spain.
Alex OlveraIrsicaixa-AIDS Research Institute, 08916 Barcelona, Spain.ORCID 0000-0002-9934-5759
IrsiCaixa · ESUniversitat de Vic - Universitat Central de Catalunya · ESInstitut d'Investigació en Ciències de la Salut Germans Trias i Pujol · ESUniversitat Autònoma de Barcelona · ES

Funding

European Union's Horizon 2020 research and innovation program 681137European Union's Horizon 2020 research and innovation program 847943
6 · The paper itself

Abstract

Despite the important role of gut microbiota in the maturation of the immune system, little is known about its impact on the development of T-cell responses to vaccination. Here, we immunized C57BL/6 mice with a prime-boost regimen using DNA plasmid, the Chimpanzee Adenovirus, and the modified Vaccinia Ankara virus expressing a candidate HIV T-cell immunogen and compared the T-cell responses between individuals with an intact or antibiotic-depleted microbiota. Overall, the depletion of the gut microbiota did not result in significant differences in the magnitude or breadth of the immunogen-specific IFNγ T-cell response after vaccination. However, we observed marked changes in the serum levels of four cytokines after vaccinating microbiota-depleted animals, particularly a significant reduction in IL-22 levels. Interestingly, the level of IL-22 in serum correlated with the abundance of

Indexed as

HIVIFNγIL-22microbiotaRoseburiaT-cellvaccine

Identifiers

PMID38005995
PMCPMC10675013
OpenAlexW4388017745

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.